Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus II”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00817778
What this trial is testing

Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Who this might be right for
Type 2 Diabetes
AstraZeneca 27
Testing effectiveness (Phase 2)Study completedNCT02005848
What this trial is testing

Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes

Who this might be right for
New Onset Type-1 Diabetes
Kamada, Ltd. 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755150
What this trial is testing

Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Chendu DIAO Pharmaceutical Group CO., LTD. 272
Testing effectiveness (Phase 2)WithdrawnNCT04062890
What this trial is testing

Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance

Who this might be right for
HyperinsulinismInsulin ResistanceInsulin Sensitivity+2 more
University of Arizona
Testing effectiveness (Phase 2)Study completedNCT00914524
What this trial is testing

Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

Who this might be right for
Chronic GlomerulonephritisDiabetic Nephropathy
Daiichi Sankyo Co., Ltd. 49
Early research (Phase 1)Study completedNCT06498284
What this trial is testing

Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type II
Hua Medicine Limited 40
Testing effectiveness (Phase 2)Study completedNCT01756716
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 49
Testing effectiveness (Phase 2)WithdrawnNCT04569214
What this trial is testing

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients

Who this might be right for
Type II Diabetes
Boston Therapeutics
Testing effectiveness (Phase 2)Study completedNCT06851858
What this trial is testing

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Who this might be right for
EndocrinologyDiabetes, Type IIObesity
AstraZeneca 69
Not applicableStudy completedNCT03755960
What this trial is testing

ACUpuncture in Diabetic Peripheral Neuropathy

Who this might be right for
Diabetic Neuropathy
Benno Brinkhaus 62
Not applicableUnknownNCT02673762
What this trial is testing

Salivary Transcriptome Biomarkers for Early Diabetes Detection

Who this might be right for
Pre-diabetesType II DiabetesInsulin Resistance
PeriRx 180
Large-scale testing (Phase 3)Study completedNCT00521742
What this trial is testing

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Who this might be right for
Diabetes Mellitus
Takeda 300
Not applicableLooking for participantsNCT06880783
What this trial is testing

Manual Diaphragmatic Release Technique on Exercise Capacity and Sleep Quality

Who this might be right for
Diabetes
Beni-Suef University 44
Not applicableWithdrawnNCT04560439
What this trial is testing

Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
City of Hope Medical Center
Not applicableActive Not RecruitingNCT05754281
What this trial is testing

The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Joslin Diabetes Center 60
Early research (Phase 1)Study completedNCT02648854
What this trial is testing

Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

Who this might be right for
Diabetes Mellitus, Type II
Chong Kun Dang Pharmaceutical 26
Post-approval studies (Phase 4)Study completedNCT00927394
What this trial is testing

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

Who this might be right for
Hypertension
Novartis 1,143
Early research (Phase 1)Study completedNCT04768673
What this trial is testing

Investigate the PK and Safety of CKD-393

Who this might be right for
Type II Diabetes
Chong Kun Dang Pharmaceutical 26
Large-scale testing (Phase 3)Study completedNCT05573477
What this trial is testing

Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes

Who this might be right for
Essential HypertensionDiabetes Mellitus, Type 2
Autotelicbio 255
Testing effectiveness (Phase 2)Study completedNCT04509791
What this trial is testing

MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)

Who this might be right for
Diabetes Mellitus, Type 1
Universitaire Ziekenhuizen KU Leuven 114
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation